News Announcement

Shilpa Medicare: Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015

Shilpa Medicare Limited has entered into a binding agreement with NXI Therapeutics AG Based out of Basel Switzerland for development supply of a New Chemical Entity (NCE)

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.